Activity

MEETING SUMMARY ✨ Chronological Template Upgrade to Premium to revert to advanced summary templates Introduction and account management @ 0:00 Andrew Hartmann from UTAK Laboratories introduced himself as the new dedicated account manager for Redwood Toxicology. He provided an overview of UTAK's customer service improvements, including assigning account managers for larger customers like Redwood. Transition to liquid urine format @ 2:18 Redwood Toxicology recently switched from frozen to liquid urine format, which saves them money. The change in preservative from the frozen to liquid form was discussed, and Redwood confirmed it works for their purposes. Exploring custom control solutions @ 4:31 UTAK offered to provide custom control solutions for Redwood, as they currently make all their controls in-house. Redwood expressed interest in exploring UTAK's offerings, citing the complexity and time required to make their own larger panels. Potential standing order for price lock @ 9:48 Redwood and UTAK discussed the possibility of a standing order for urine to lock in pricing for a 2-year period, which could provide cost savings for Redwood. They agreed to explore this further. Evaluation of synthetic oral fluid @ 20:17 UTAK offered to provide samples of their synthetic oral fluid product for Redwood to evaluate, as they currently struggle to obtain real human oral fluid samples that meet their requirements. Feedback on UTAK partnership @ 23:26 Redwood provided feedback that UTAK's product consistency and reliability are valuable, but pricing is a concern. They rated UTAK an 8 out of 10 overall. Next steps @ 27:24 UTAK agreed to follow up on the potential 2-year standing order pricing, as well as send samples of their synthetic urine and oral fluid products for Redwood to evaluate.